News | January 04, 2022
Domestic and emerging markets will drive pharma growth: ICRA
Healthy growth in domestic and emerging markets is expected to support revenue growth in the next few quarters
Healthy growth in domestic and emerging markets is expected to support revenue growth in the next few quarters
Partnering to build biosynthesis processes and a pharmaceutical production platform
The approval of shelf life extension is based on the availability of additional stability data, which was submitted to the CDSCO
Atik Cameras invests in new CCD sensor technology to create an advanced scientific and industrial imaging solution, using the Teledyne e2v CCD77-00 sensor
_256_384.jpg)
Primary endpoints and secondary endpoints for which data are available were met in trial dominated by Covid-19 variants
The companies expect to manufacture over 80 million does of the Covid-19 vaccine in 2022
.jpg)
Molbio Diagnostics has been the pioneer in providing access to molecular testing through its Truenat Real Time PCR platform. Sriram Natarajan, Director & CEO, of the company shares his experiences on the journey so far in an interview with Thomas C Thottathil
A CRISIL study of 207 pharmaceutical companies that account for 55% of the Rs 3.2 lakh crore-a-year sector revenue indicates as much.
The new manufacturing facility will be built at a subsidiary of Adcock Ingram and will commence operation in March 23
The transplant procedure was completed in under two hours
Subscribe To Our Newsletter & Stay Updated
